PHC Holdings acquired Thermo Fisher Scientific’s anatomical pathology business in 2019 for around $1.14bn. Following the acquisition, the business was renamed to Epredia. According to GlobalData ...

The precision cancer business of PHC Holdings anticipates an increase in cancer cases and is expanding its digital pathology and immunohistochemistry instrument lineup.

Affinity Technologies today announced strategic actions to cut $4 million in annual costs at its subsidiary CAP/CLIA ...

Anatomical reference points were selected to form a triangle ... This paper forms part of a series addressing the three-dimensional nature of proximal lower limb pathology. The 3G approach (groin, ...